With the rise of drugs that show unstable supply and the consequent rise in drugs requesting pricing adjustments, the National Health Insurance Service plans to establish a guideline for smooth pricing adjustment negotiations and disclose it soon.

The NHIS recently completed expert consultations and is currently revising the final draft.

According to industry sources on the 13th, the NHIS had started establishing a guideline for the pricing adjustment negotiations to simplify materials requiring submissions and ensure accurate cost analysis.

Also, the authorities had collected opinions from the industry after establishing a consultative body with the Korea Pharmaceutical a